Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Lysophosphatidic acid (LPA) is a ubiquitous lysophospholipid and one of the main membrane-derived lipid signaling molecules. LPA acts as an autocrine/paracrine messenger through at least six G protein-coupled receptors (GPCRs), known as LPA1-6, to induce various cellular processes including wound he...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_1c8d7c0688dc45e1a31c44eefac8e0a5 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Silvia Anahi Valdés-Rives |e author |
700 | 1 | 0 | |a Aliesha González-Arenas |e author |
245 | 0 | 0 | |a Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development |
260 | |b Hindawi Limited, |c 2017-01-01T00:00:00Z. | ||
500 | |a 0962-9351 | ||
500 | |a 1466-1861 | ||
500 | |a 10.1155/2017/9173090 | ||
520 | |a Lysophosphatidic acid (LPA) is a ubiquitous lysophospholipid and one of the main membrane-derived lipid signaling molecules. LPA acts as an autocrine/paracrine messenger through at least six G protein-coupled receptors (GPCRs), known as LPA1-6, to induce various cellular processes including wound healing, differentiation, proliferation, migration, and survival. LPA receptors and autotaxin (ATX), a secreted phosphodiesterase that produces this phospholipid, are overexpressed in many cancers and impact several features of the disease, including cancer-related inflammation, development, and progression. Many ongoing studies aim to understand ATX-LPA axis signaling in cancer and its potential as a therapeutic target. In this review, we discuss the evidence linking LPA signaling to cancer-related inflammation and its impact on cancer progression. | ||
546 | |a EN | ||
690 | |a Pathology | ||
690 | |a RB1-214 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Mediators of Inflammation, Vol 2017 (2017) | |
787 | 0 | |n http://dx.doi.org/10.1155/2017/9173090 | |
787 | 0 | |n https://doaj.org/toc/0962-9351 | |
787 | 0 | |n https://doaj.org/toc/1466-1861 | |
856 | 4 | 1 | |u https://doaj.org/article/1c8d7c0688dc45e1a31c44eefac8e0a5 |z Connect to this object online. |